Privia Health Group, Inc. (PRVA) Earns Top Pick Status from TD Cowen

Privia Health Group, Inc. (NASDAQ:PRVA) is among the best NASDAQ stocks under $50 to buy. Analysts at TD Cowen have named Privia Health Group, Inc. (NASDAQ:PRVA) its “Best Smidcap Idea” while maintaining a Buy rating and a $30.00 price target. This potential surge of about 31% from the current price is driven by the company’s robust financial footing, which includes zero debt and more than $400 million in cash.

Over the years, Privia Health Group, Inc. (NASDAQ:PRVA) has delivered improved results, with PRVA’s 17.08% year-to-date return surpassing the market’s 2.58% return. The leading investment bank believes that the company possesses the potential to deliver more than 20% EBITDA growth not only in 2025 but also in 2026. This is anything but ordinary, given the current market pessimism.

A physician leveraging innovative technology to enable their patient care decisions.

What makes Privia Health Group, Inc. (NASDAQ:PRVA) stand out the most is its capital-light business model that yields positive free cash flow in addition to maintaining impressive EBITDA growth. The analysts believe that this is the perfect blend for the powerhouse’s scalable and predictable business operation.

Privia Health Group, Inc. (NASDAQ:PRVA) is a Virginia-based physician-enablement company that partners with physician practices, health plans, and health systems to provide technology and population health tools. Founded in 2007, the company also manages an accountable care organization for enhanced coordination and patient quality metrics.

While we acknowledge the potential of PRVA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None.